Fundraising Fox

Biotech Investors & VC Firms in United States

564 firms in this list, with a median first check of $500K. 46 of them lead rounds. Generated from verified public data and updated continuously.

Forepont Capital Partners
New YorkSeed–Late Stage
7 people
H.I.G. HealthBridge Partners
MiamiGrowth$5M – $40M
4 people
i&i Biotech Fund
PragueSeed–Series B$162K – $2.2M
4 people
JDRF T1D Fund
BostonSeed–Late Stage
7 people
Metavallon VC
AtticaPre-Seed–Series A$540K – $1.6M
4 people
New Rhein Healthcare Investors, LLC
PhiladelphiaSeries A–Late Stage
7 people
Newlin Investment Company LLC
SewickleySeed–Series B$100K – $3M
4 people
Red Tree Venture
Redwood CitySeed–Series A
7 people
Samsara BioCapital
Palo AltoSeed–Late Stage
7 people
The Finnish Innovation Fund Sitra
HelsinkiSeed–Late Stage$108K
4 people
Unfold Ventures
WroclawPre-Seed–Series A$108K – $1.1M
4 people
Verge Fund
AlbuquerquePre-Seed–Series A$100K – $500K
4 people
Virtus Inspire Ventures
Seed–Series A
7 people
SeaX Ventures
BangkokPre-Seed–Series A$100K – $5M
3 people
Claremont Creek Ventures
OaklandSeed–Late Stage$500K – $3M
3 people
Dimension Capital
Coral GablesSeed–Late Stage
5 people
BIOSPRING PARTNERS
BostonGrowth–Late Stage
6 people
Dementia Discovery
LondonSeed–Series A
6 people
Embark Ventures
Los AngelesPre-Seed–Seed
Excell Partners
RochesterPre-Seed–Series A$100K – $500K
3 people
Spruce Capital Partners
South San FranciscoSeries A–Growth
3 people
Circadian Ventures
AtlantaSeed–Series A$500K – $1.5M
2 people
Auriga Partners
ParisSeed–Series A$540K – $5.4M
3 people
Bay City Capital
San RafaelSeed–Late Stage$5M – $10M
3 people

Related lists

Data sourced from public filings and firms' own websites — see our methodology.